RNA-ISH technology with RNAscope has already been used to for human breast cancer to determine HER2 mRNA levels in equivocal cases (IHC 2+ or a Fluorescence ISH ratio of 1.8 to 2.2) and has displayed better performance than that by qPCR [35]. This evidence concerns the gene ERBB2 and breast carcinoma.